Bio Protocol vs THORChain — how do they compare? Bio Protocol trades at Rp492.75 (market cap Rp1,1T, Rp300,52M 24h volume), while THORChain trades at Rp7,359 (market cap Rp2,48T, Rp128,57M 24h volume). The key difference: THORChain is far larger — about 2.3× Bio Protocol's market cap, and Bio Protocol's circulating supply is 2,2B / 3,3B BIO (68%) versus 338,3M / 354,2M RUNE (96%) for THORChain. Which is the better fit depends on your goals — on Pluang, investors hold Bio Protocol for 16 Days and THORChain for 47 Days on average.
| BIO | RUNE | |
|---|---|---|
Market Cap | Rp1,1T | Rp2,48T |
Volume (24h) | Rp300,52M | Rp128,57M |
Circulating Supply | 2,2B / 3,3B BIO (68%) | 338,3M / 354,2M RUNE (96%) |
Typical Hold Time | 16 Days | 47 Days |
Signals from Pluang's Aura AI — not financial advice
Bio Protocol (BIO) trades at Rp514.67 with a market cap of Rp1.15 trillion, showing a bearish technical signal as moving averages indicate selling pressure. The token's circulating supply is 2.2 million out of 3.3 million, with a 68% circulation rate and average hold time of 16 days. Recent news highlights participation in blockchain and tech events, though no major protocol upgrades were reported in the last month.
Overall outlook remains cautious due to bearish technicals and neutral oscillators. Key opportunities include potential rebound from oversold RSI levels near support at Rp474. Major risks involve low liquidity, regulatory uncertainty in Indonesia, and high volatility typical of small-cap cryptocurrencies.
THORChain (RUNE) is trading at Rp7,393 with a market cap of Rp2.5 trillion, showing bullish technical signals from moving averages while oscillators remain neutral. The token operates near key support at Rp7,232 with resistance at Rp7,325. With 96% of max supply in circulation and average hold time of 47 days, the network demonstrates strong token distribution.
Overall outlook remains cautiously optimistic with technical momentum favoring bulls, though neutral oscillators suggest potential consolidation. Key opportunities include protocol adoption growth, while risks involve crypto market volatility and regulatory uncertainty. Investors should monitor support levels for entry points.
What Pluang investors did over the last 30 days
BIO Protocol enables global communities of scientists, patients, and investors to collectively fund, develop, and co-own new drugs and therapeutics through its network of Biotech Decentralized Autonomous Organizations (BioDAOs). The protocol's innovative approach addresses critical gaps in traditional scientific funding, particularly in areas such as rare diseases, longevity research, and emerging health challenges.
Read more on BIO →THORCHain is a decentralized liquidity protocol that allows users to easily exchange cryptocurrency assets across a range of networks without losing full custody of their assets in the process. With THORChain, users can simply swap one asset for another in a permissionless setting, without needing to rely on order books to source liquidity. The native utility token of the THORChain platform is RUNE.
Read more on RUNE →